Accurate Solution for Early Assessment of Osteoporosis at the Point of Care 7000 Millions of people worldwide are at risk of developing osteoporosis, and millions more already suffer from it. Early assessment and ongoing monitoring are key to positive outcomes. With the Sunlight Omnisense™ 7000 Quantitative Ultrasound Bone Sonometer you can offer reliable, accurate, non-invasive and safe diagnosis and monitoring of the disease - with exceptional cost-effectiveness and ease, right at the point of care. A compact device designed for any clinic or physician office, Omnisense 7000 provides a proven, ideal way to manage and monitor osteoporosis diagnosis and treatment for any patient. Proven Accuracy Omnisense 7000 is based on proprietary Sunlight Omnipath™ quantitative ultrasound technology, which has been proven - in thousands of Sunlight Omnisense installations worldwide - to deliver highly accurate and safe multi-site measurement of bone density. Omnisense 7000 leads the Sunlight family of Omnipath-based solutions – the first, and currently only, multi-site ultrasound devices available today that enable first-line early assessment and diagnosis of osteoporosis. It offers an effective alternative to the traditional x-ray-based scans where use of DXA for diagnosis or monitoring is not possible due to cost or geographic limitations of available systems and whenever x-ray exposure should be avoid

7000 The Omnisense™ 7000 Advantage • Proven safety - Radiation-free & non-invasive - Utilizes market-proven Omnipath technology High accuracy - Precise measurements – a unique multi-site measurement option - 4 ethnical reference databases for males, females and children Easy to use - Built-in patient data management - Low system cost; no disposables Advanced capabilities - Supports Sunlight PREMIER and Pediatric software for bone density assessment in premature babies and children aged 0-18 respectively - Can be connected to Tetrax and Sunlight BonAge devices for expanded applications Tibia Omnipath™...